Jaqueline Corrigan-Curay, who serves as acting head of the FDA’s Center for Drug Evaluation and Research, will depart next ...

Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...